Open Access

SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression

  • Authors:
    • Yusuke Nakano
    • Takaaki Masuda
    • Takeharu Sakamoto
    • Noritaka Tanaka
    • Taro Tobo
    • Masahiro Hashimoto
    • Takanari Tatsumi
    • Hideyuki Saito
    • Junichi Takahashi
    • Kensuke Koike
    • Tadashi Abe
    • Yuki Ando
    • Yuki Ozato
    • Kiyotaka Hosoda
    • Kosuke Hirose
    • Satoshi Higuchi
    • Tomohiko Ikehara
    • Yuichi Hisamatsu
    • Takeo Toshima
    • Yusuke Yonemura
    • Takayuki Ogino
    • Mamoru Uemura
    • Hidetoshi Eguchi
    • Yuichiro Doki
    • Koshi Mimori
  • View Affiliations

  • Published online on: October 21, 2024     https://doi.org/10.3892/ijo.2024.5701
  • Article Number: 113
  • Copyright: © Nakano et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is widely prevalent and represents a significant contributor to global cancer‑related mortality. There remains a pressing demand for advancements in CRC treatment modalities. The E3 ubiquitin ligase is a critical enzyme involved in modulating protein expression levels via posttranslational ubiquitin‑mediated proteolysis, and it is reportedly involved in the progression of various cancers, making it a target of recent interest in anticancer therapy. In the present study, using comprehensive expression analysis involving spatial transcriptomic analysis with single‑cell RNA sequencing in clinical CRC datasets, the ubiquitin‑associated protein Shank‑associated RH domain interactor (SHARPIN) was identified, located on amplified chromosome 8q, which could promote CRC progression. SHARPIN was found to be upregulated in tumor cells, with elevated expression observed in tumor tissues. This heightened expression of SHARPIN was positively associated with lymphatic invasion and served as an independent predictor of a poor prognosis in patients with CRC. In vitro and in vivo analyses using SHARPIN‑overexpressing or ‑knockout CRC cells revealed that SHARPIN overexpression upregulated MDM2, resulting in the downregulation of p53, while SHARPIN silencing or knockout downregulated MDM2, leading to p53 upregulation, which affects cell cycle progression, tumor cell apoptosis and tumor growth in CRC. Furthermore, SHARPIN was found to be overexpressed in several cancer types, exerting significant effects on survival outcomes. In conclusion, SHARPIN represents a newly identified novel gene with the potential to promote tumor growth following apoptosis inhibition and cell cycle progression in part by inhibiting p53 expression via MDM2 upregulation; therefore, SHARPIN represents a potential therapeutic target for CRC.
View Figures
View References

Related Articles

Journal Cover

December-2024
Volume 65 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nakano Y, Masuda T, Sakamoto T, Tanaka N, Tobo T, Hashimoto M, Tatsumi T, Saito H, Takahashi J, Koike K, Koike K, et al: <em>SHARPIN</em> is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression. Int J Oncol 65: 113, 2024.
APA
Nakano, Y., Masuda, T., Sakamoto, T., Tanaka, N., Tobo, T., Hashimoto, M. ... Mimori, K. (2024). <em>SHARPIN</em> is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression. International Journal of Oncology, 65, 113. https://doi.org/10.3892/ijo.2024.5701
MLA
Nakano, Y., Masuda, T., Sakamoto, T., Tanaka, N., Tobo, T., Hashimoto, M., Tatsumi, T., Saito, H., Takahashi, J., Koike, K., Abe, T., Ando, Y., Ozato, Y., Hosoda, K., Hirose, K., Higuchi, S., Ikehara, T., Hisamatsu, Y., Toshima, T., Yonemura, Y., Ogino, T., Uemura, M., Eguchi, H., Doki, Y., Mimori, K."<em>SHARPIN</em> is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression". International Journal of Oncology 65.6 (2024): 113.
Chicago
Nakano, Y., Masuda, T., Sakamoto, T., Tanaka, N., Tobo, T., Hashimoto, M., Tatsumi, T., Saito, H., Takahashi, J., Koike, K., Abe, T., Ando, Y., Ozato, Y., Hosoda, K., Hirose, K., Higuchi, S., Ikehara, T., Hisamatsu, Y., Toshima, T., Yonemura, Y., Ogino, T., Uemura, M., Eguchi, H., Doki, Y., Mimori, K."<em>SHARPIN</em> is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression". International Journal of Oncology 65, no. 6 (2024): 113. https://doi.org/10.3892/ijo.2024.5701